• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.

作者信息

Jiang Xia, Song Ting-Ting, Hao Fei

机构信息

Dermatology and Plastic Surgery Center, The Third Affiliated Hospital of Chongqing Medical University (General Hospital), Chongqing, China.

出版信息

Indian J Dermatol Venereol Leprol. 2021;87(4):548-551. doi: 10.25259/IJDVL_288_20.

DOI:10.25259/IJDVL_288_20
PMID:34219432
Abstract
摘要

相似文献

1
Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.厄洛替尼诱发的反应性穿通性胶原病一例肺腺癌患者
Indian J Dermatol Venereol Leprol. 2021;87(4):548-551. doi: 10.25259/IJDVL_288_20.
2
Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.与索拉非尼相关的罕见皮疹：一例获得性穿通性皮肤病，反应性穿通性胶原病型。
Dermatol Online J. 2018 Dec 15;24(12):13030/qt8b40k5kg.
3
Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer.与厄洛替尼治疗肺癌相关的肾小管间质性肾炎。
Nephrology (Carlton). 2020 Sep;25(9):730. doi: 10.1111/nep.13721. Epub 2020 May 20.
4
Reactive perforating collagenosis during erlotinib therapy.厄洛替尼治疗期间的反应性穿通性胶原病
Acta Derm Venereol. 2012 Mar;92(2):216-7. doi: 10.2340/00015555-1248.
5
Acquired reactive perforating collagenosis: current status.获得性反应性穿孔性胶原病：现状。
J Dermatol. 2010 Jul;37(7):585-92. doi: 10.1111/j.1346-8138.2010.00918.x.
6
Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer.厄洛替尼治疗肺癌导致的纵向拇指指甲裂。
J Oncol Pharm Pract. 2018 Apr;24(3):229-231. doi: 10.1177/1078155217698845. Epub 2017 Mar 12.
7
Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient.心脏移植患者中表皮生长因子受体阳性肺腺癌的治疗
Monaldi Arch Chest Dis. 2019 May 30;89(2). doi: 10.4081/monaldi.2019.1023.
8
[A Case of Lung Adenocarcinoma Presenting with Leptomeningeal Carcinomatosis Successfully Treated with Afatinib after Erlotinib-Induced Hepatotoxicity].[一例肺腺癌伴软脑膜癌病患者在厄洛替尼诱发肝毒性后成功接受阿法替尼治疗的病例]
Gan To Kagaku Ryoho. 2017 Jul;44(7):595-597.
9
Necrolytic migratory erythema-like eruption associated with erlotinib in a patient with lung adenocarcinoma.一名肺腺癌患者中与厄洛替尼相关的坏死性游走性红斑样皮疹
Lung Cancer. 2020 Oct;148:173-174. doi: 10.1016/j.lungcan.2020.07.030. Epub 2020 Jul 31.
10
Erlotinib-related keratopathy in a patient underwent laser in situ keratomileusis.
Cutan Ocul Toxicol. 2016 Sep;35(3):257-9. doi: 10.3109/15569527.2015.1072546. Epub 2015 Aug 12.

引用本文的文献

1
Aging and tumors: a dynamic interaction.衰老与肿瘤：一种动态相互作用。
Discov Oncol. 2025 Jan 21;16(1):68. doi: 10.1007/s12672-025-01808-9.
2
Acquired reactive perforating collagenosis secondary to Cabozantinib: A case report and literature review.卡博替尼继发的获得性反应性穿通性胶原病：一例报告及文献复习
SAGE Open Med Case Rep. 2024 Dec 16;12:2050313X241304961. doi: 10.1177/2050313X241304961. eCollection 2024.
3
Perforating Gout: Expanding the Differential for Transepidermal Elimination.穿通性痛风：扩大经表皮消除的鉴别诊断范围

本文引用的文献

1
Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®)).肺癌患者使用厄洛替尼（特罗凯（®））治疗期间出现的痤疮样皮疹。
Postepy Dermatol Alergol. 2013 Jun;30(3):195-8. doi: 10.5114/pdia.2013.35624. Epub 2013 Jun 20.
2
Reactive perforating collagenosis during erlotinib therapy.厄洛替尼治疗期间的反应性穿通性胶原病
Acta Derm Venereol. 2012 Mar;92(2):216-7. doi: 10.2340/00015555-1248.
3
Acquired reactive perforating collagenosis: current status.获得性反应性穿孔性胶原病：现状。
Dermatopathology (Basel). 2023 Jul 12;10(3):207-218. doi: 10.3390/dermatopathology10030029.
J Dermatol. 2010 Jul;37(7):585-92. doi: 10.1111/j.1346-8138.2010.00918.x.
4
Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis.西罗莫司诱导的炎性丘疹伴获得性反应性穿通性胶原病。
Dermatology. 2008;216(3):239-42. doi: 10.1159/000112934. Epub 2008 Jan 9.